086900Medy-Tox086900 info
$136.45info0.00%24h
Global rank8235
Market cap$918.33M
Change 7d-8.12%
YTD Performance-24.74%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Medy-Tox (086900) Stock Overview

    Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and internationally. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea.

    086900 Stock Information

    Symbol
    086900
    Address
    78, Gak-ri 1-gilCheongju, South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.medy-tox.co.kr
    Country
    🇰🇷 South Korea
    Phone Number
    82 4 3217 1555

    Medy-Tox (086900) Price Chart

    -
    Value:-

    Medy-Tox Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $136.45
    N/A
    Market Cap
    $918.33M
    N/A
    Shares Outstanding
    6.73M
    N/A
    Employees
    728.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org